Atossa Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
10 Apr 24 | Buy€41,179 | Jonathan Finn | Individual | 25,000 | €1.65 | |
15 Nov 23 | Sell€29,916 | Gregory Weaver | Individual | 50,000 | €0.60 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 22,254 | 0.0177% |
Individual Insiders | 51,158 | 0.0407% |
VC/PE Firms | 7,762,500 | 6.17% |
Institutions | 26,592,135 | 21.1% |
General Public | 91,329,369 | 72.6% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
9,197,040 | €12.4m | 234% | no data | |||
7,762,500 | €10.5m | 0% | 3.96% | |||
6,485,877 | €8.8m | 12.7% | no data | |||
2,769,684 | €3.7m | 128% | no data | |||
1,663,041 | €2.2m | 237% | no data | |||
1,550,910 | €2.1m | 11.9% | no data | |||
431,861 | €584.0k | -43.6% | no data | |||
411,667 | €556.7k | 3,160% | no data | |||
369,988 | €500.4k | 705% | no data | |||
267,208 | €361.4k | 18.4% | no data | |||
260,081 | €351.7k | 566% | no data | |||
250,398 | €338.6k | 0% | 0.03% | |||
209,241 | €283.0k | 36.7% | no data | |||
201,498 | €272.5k | 59.9% | no data | |||
182,786 | €247.2k | 450% | no data | |||
170,733 | €230.9k | 0% | no data | |||
157,426 | €212.9k | -36.7% | no data | |||
135,118 | €182.7k | 0% | no data | |||
105,910 | €143.2k | 0% | no data | |||
103,872 | €140.5k | 35.6% | no data | |||
102,665 | €138.8k | -83.7% | no data | |||
87,800 | €118.7k | 0% | no data | |||
75,126 | €101.6k | -10.5% | 0.01% | |||
71,411 | €96.6k | 22.8% | no data | |||
68,049 | €92.0k | 17.2% | no data |